| Target ID: | dt754 |
|---|---|
| CID: | 5281004 |
| Compound Name: | Budesonide |
| Gene ID: | 3458 |
| Gene Name: | IFNG |
| Species: | Homo sapiens (human) |
| PubMed IDs: | 16160912 |
| Action: | [zafirlukast co-treated with prednisone co-treated with budesonide] inhibits the reaction [antigens results in increased secretion of IFNG protein] |
Knowledge Graph
| Target ID | CID | Compound Name | Gene ID | Gene Name | Species | Action | |
|---|---|---|---|---|---|---|---|
| dt142 | 2907 | Cyclophosphamide | 3458 | IFNG | Homo sapiens (human) | -- | Details |
| dt753 | 5281004 | Budesonide | 3458 | IFNG | Homo sapiens (human) | Budesonide results in decreased secretion of IFNG protein | Details |
| dt817 | 5337997 | Nifuroxazide | 3458 | IFNG | Homo sapiens (human) | Nifuroxazide inhibits the reaction [[IFNG protein co-treated with TNF protein] results in increased expression of CCL17 mrna]|nifuroxazide inhibits the reaction [[IFNG protein co-treated with TNF protein] results in increased expression of CCL22 mrna] | Details |
| Drug ID | Drug Name | Type | DrugBank ID | Targets | Category | Latest Progress | |
|---|---|---|---|---|---|---|---|
| Drug89 | Budesonide | Chemical drug | -- | -- | -- | Under clinical trials | Details |
| Compound ID | Source ID | Source Type | Compound Name | Molecular Weight | Molecular Formula | Molecular Species | |
|---|---|---|---|---|---|---|---|
| No data available | |||||||
| Disease ID | Disease Name | Definition | Mechanism | |
|---|---|---|---|---|
| No data available | ||||
| Strategy ID | Therapy Strategy | Synonyms | Related Drugs | Mechanism | |
|---|---|---|---|---|---|
| No data available | |||||